Tech Company Financing Transactions
TetraLogic Pharmaceuticals Funding Round
TetraLogic Pharmaceuticals secured a $23 million Series C funding round on 1/5/2011. Investors included Clarus, Amgen Ventures and Hatteras Venture Partners.
Transaction Overview
Clarus (Lead Investor) (Michael Steinmet)
Hatteras Venture Partners (Douglas Reed)
HealthCare Ventures (Harold Werner)
Latterell Venture Partners (James Woody)
Novitas Capital (Paul Schmitt)
Quaker Partners (Brenda Gavin)
Company Information
Malvern, PA 19355
USA
Management Team
Browse more venture capital transactions:
Prev: 1/5/2011: Gliknik venture capital transaction
Next: 1/5/2011: SoloPower venture capital transaction
Share this article
News on VC Transactions
We report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs